These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 36183106)

  • 1. Huc-MSC-derived exosomes modified with the targeting peptide of aHSCs for liver fibrosis therapy.
    Lin Y; Yan M; Bai Z; Xie Y; Ren L; Wei J; Zhu D; Wang H; Liu Y; Luo J; Li X
    J Nanobiotechnology; 2022 Oct; 20(1):432. PubMed ID: 36183106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human umbilical cord mesenchymal stem cells inhibit liver fibrosis via the microRNA-148a-5p/SLIT3 axis.
    Yuan M; Yao L; Chen P; Wang Z; Liu P; Xiong Z; Hu X; Li L; Jiang Y
    Int Immunopharmacol; 2023 Dec; 125(Pt A):111134. PubMed ID: 37918086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ectodysplasin-A mRNA in exosomes released from activated hepatic stellate cells stimulates macrophage response.
    Marrero E; Attal N; Nimeri A; McGee RM; Benbow JH; Thompson KJ; Schrum LW; McKillop IH
    Exp Cell Res; 2022 Oct; 419(2):113297. PubMed ID: 35964664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PDGFRβ-targeted TRAIL specifically induces apoptosis of activated hepatic stellate cells and ameliorates liver fibrosis.
    Li R; Li Z; Feng Y; Yang H; Shi Q; Tao Z; Cheng J; Lu X
    Apoptosis; 2020 Feb; 25(1-2):105-119. PubMed ID: 31894448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BMP7-Loaded Human Umbilical Cord Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Ameliorate Liver Fibrosis by Targeting Activated Hepatic Stellate Cells.
    Zhu D; Sun Z; Wei J; Zhang Y; An W; Lin Y; Li X
    Int J Nanomedicine; 2024; 19():3475-3495. PubMed ID: 38623080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cell-derived exosomes protect against liver fibrosis via delivering miR-148a to target KLF6/STAT3 pathway in macrophages.
    Tian S; Zhou X; Zhang M; Cui L; Li B; Liu Y; Su R; Sun K; Hu Y; Yang F; Xuan G; Ma S; Zheng X; Zhou X; Guo C; Shang Y; Wang J; Han Y
    Stem Cell Res Ther; 2022 Jul; 13(1):330. PubMed ID: 35858897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemically modified liposomes carrying TRAIL target activated hepatic stellate cells and ameliorate hepatic fibrosis in vitro and in vivo.
    Li Q; Ding Y; Guo X; Luo S; Zhuang H; Zhou J; Xu N; Yan Z
    J Cell Mol Med; 2019 Mar; 23(3):1951-1962. PubMed ID: 30592139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomes derived from miR-181-5p-modified adipose-derived mesenchymal stem cells prevent liver fibrosis via autophagy activation.
    Qu Y; Zhang Q; Cai X; Li F; Ma Z; Xu M; Lu L
    J Cell Mol Med; 2017 Oct; 21(10):2491-2502. PubMed ID: 28382720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CREKA-modified liposomes target activated hepatic stellate cells to alleviate liver fibrosis by inhibiting collagen synthesis and angiogenesis.
    Li R; Zhang J; Liu Q; Tang Q; Jia Q; Xiong Y; He J; Li Y
    Acta Biomater; 2023 Sep; 168():484-496. PubMed ID: 37392933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Umbilical Cord Mesenchymal Stem Cells Ameliorate Hepatic Stellate Cell Activation and Liver Fibrosis by Upregulating MicroRNA-455-3p through Suppression of p21-Activated Kinase-2.
    Zhou Q; Gu T; Zhang Y; Li H; Zhuansun X; Xu S; Kuang Y
    Biomed Res Int; 2021; 2021():6685605. PubMed ID: 33708992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review of the anti-inflammatory and anti-fibrotic potential of human umbilical cord mesenchymal stem cells-derived exosomes in experimental models of liver regeneration.
    Puspita R; Jusuf AA; Antarianto RD; Sianipar IR
    Mol Biol Rep; 2024 Sep; 51(1):999. PubMed ID: 39302506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory mechanism of DHRS2-modified human umbilical cord mesenchymal stem cells-derived exosomes in prostate cancer cell proliferation and apoptosis.
    Wu X; Zeng Z; Peng K; Ren D; Zhang L
    Tissue Cell; 2023 Jun; 82():102078. PubMed ID: 37060745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered Exosomes With Ischemic Myocardium-Targeting Peptide for Targeted Therapy in Myocardial Infarction.
    Wang X; Chen Y; Zhao Z; Meng Q; Yu Y; Sun J; Yang Z; Chen Y; Li J; Ma T; Liu H; Li Z; Yang J; Shen Z
    J Am Heart Assoc; 2018 Aug; 7(15):e008737. PubMed ID: 30371236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic Evolution of Ligands by Exosome Enrichment: A Proof-of-Concept Study for Exosome-Based Targeting Peptide Screening.
    Liu X; Yang X; Sun W; Wu Q; Song Y; Yuan L; Yang G
    Adv Biosyst; 2019 Feb; 3(2):e1800275. PubMed ID: 32627374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic PEGylated TRAIL treatment ameliorates liver cirrhosis in rats by eliminating activated hepatic stellate cells.
    Oh Y; Park O; Swierczewska M; Hamilton JP; Park JS; Kim TH; Lim SM; Eom H; Jo DG; Lee CE; Kechrid R; Mastorakos P; Zhang C; Hahn SK; Jeon OC; Byun Y; Kim K; Hanes J; Lee KC; Pomper MG; Gao B; Lee S
    Hepatology; 2016 Jul; 64(1):209-23. PubMed ID: 26710118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research Progress on the Effect of Autophagy and Exosomes on Liver Fibrosis.
    Du Y; Zhu S; Zeng H; Wang Z; Huang Y; Zhou Y; Zhang W; Zhu J; Yang C
    Curr Stem Cell Res Ther; 2024; 19(6):785-797. PubMed ID: 37102476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells improve liver fibrosis and protect hepatocytes by promoting microRNA-148a-5p-mediated inhibition of Notch signaling pathway.
    Zhou Q; Rong C; Gu T; Li H; Wu L; Zhuansun X; Zhao X; Xiao Z; Kuang Y; Xu S; Wang S
    Stem Cell Res Ther; 2022 Jul; 13(1):354. PubMed ID: 35883205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human umbilical cord mesenchymal stem cell-derived exosomes inhibit ovarian granulosa cells inflammatory response through inhibition of NF-κB signaling in polycystic ovary syndrome.
    Zhao Y; Pan S; Wu X
    J Reprod Immunol; 2022 Aug; 152():103638. PubMed ID: 35588629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-derived growth factor receptor β-targeted positron emission tomography imaging for the noninvasive monitoring of liver fibrosis.
    Li Z; Yang H; Li X; She T; Tao Z; Zhong Y; Su T; Feng Y; Shi Q; Li L; Tian R; Wang S; Cheng J; Cai H; Lu X
    Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1530-1543. PubMed ID: 38189910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver fibrosis therapy based on biomimetic nanoparticles which deplete activated hepatic stellate cells.
    Xia S; Liu Z; Cai J; Ren H; Li Q; Zhang H; Yue J; Zhou Q; Zhou T; Wang L; Liu X; Zhou X
    J Control Release; 2023 Mar; 355():54-67. PubMed ID: 36693527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.